Osteoarthritis year in review 2015: Biology

Osteoarthritis and Cartilage

Volumn 24, Issue 1, 2016, Pages 21-26

  Malfait, A M ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cartilage; Chondrocytes; Inflammation; Osteoarthritis; Pain; Synovium

Indexed keywords

AGGRECAN; ALARMIN; CALCITONIN GENE RELATED PEPTIDE; CALGRANULIN A; CALGRANULIN B; CHEMOKINE RECEPTOR CXCR2; ETANERCEPT; GRANULOCYTE CHEMOTACTIC PROTEIN 2; INTERLEUKIN 1; MESSENGER RNA; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR ANTIBODY; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; POLYUNSATURATED FATTY ACID; PROTEINASE ACTIVATED RECEPTOR 2; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SODIUM CHANNEL NAV1.7; SODIUM CHANNEL NAV1.8; TOLL LIKE RECEPTOR 2; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR MTF1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ZINC; ZINC TRANSPORTER; ZIP8 PROTEIN; ALPHA CHEMOKINE; CATION TRANSPORT PROTEIN; DNA BINDING PROTEIN; SCN10A PROTEIN, HUMAN; SCN9A PROTEIN, HUMAN; TLR2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR MTF-1; ZIP8 PROTEIN, HUMAN;

ADIPOSE DERIVED STEM CELL; AGING; ARTICULAR CARTILAGE; AUTOPHAGY; CALORIC RESTRICTION; CARTILAGE DEGENERATION; CHRONIC DISEASE; HUMAN; KNEE MENISCUS RUPTURE; KNEE OSTEOARTHRITIS; MACROPHAGE ACTIVATION; NONHUMAN; OBESITY; OSTEOARTHRITIS; OSTEOPHYTE; OXIDATIVE STRESS; PAIN; POSTTRAUMATIC ARTHROPATHY; POSTTRAUMATIC OSTEOARTHRITIS; PRIORITY JOURNAL; REVIEW; SINGLE DRUG DOSE; SYNOVITIS; INFLAMMATION; METABOLISM; SYNOVIUM;

AUTOPHAGY; CALCITONIN GENE-RELATED PEPTIDE; CALGRANULIN A; CARTILAGE, ARTICULAR; CATION TRANSPORT PROTEINS; CHEMOKINES, CXC; DNA-BINDING PROTEINS; HUMANS; INFLAMMATION; NAV1.7 VOLTAGE-GATED SODIUM CHANNEL; NAV1.8 VOLTAGE-GATED SODIUM CHANNEL; NERVE GROWTH FACTOR; OBESITY; OSTEOARTHRITIS; OXIDATIVE STRESS; SYNOVIAL MEMBRANE; SYNOVITIS; TOLL-LIKE RECEPTOR 2; TRANSCRIPTION FACTORS; ZINC;

EID: 84951786726     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2015.09.010     Document Type: Review

References (43)

1. Loeser R.F., Goldring S.R., Scanzello C.R., Goldring M.B. Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum 2012, 64(6):1697-1707.
2. Little C.B., Hunter D.J. Post-traumatic osteoarthritis: from mouse models to clinical trials. Nat Rev Rheumatol 2013, 9(8):485-497.
3. Liu-Bryan R., Terkeltaub R. Emerging regulators of the inflammatory process in osteoarthritis. Nat Rev Rheumatol 2015, 11(1):35-44.
4. Goldring M.B., Otero M. Inflammation in osteoarthritis. Curr Opin Rheumatol 2011, 23(5):471-478.
5. Tew S.R., McDermott B.T., Fentem R.B., Peffers M.J., Clegg P.D. Transcriptome-wide analysis of messenger RNA decay in normal and osteoarthritic human articular chondrocytes. Arthritis Rheumatol 2014, 66(11):3052-3061.
6. Sherwood J., Bertrand J., Nalesso G., Poulet B., Pitsillides A., Brandolini L., et al. A homeostatic function of CXCR2 signalling in articular cartilage. Ann Rheum Dis 2014, [Epub ahead of print]. 10.1136/annrheumdis-2014-205546.
7. Kim J.H., Jeon J., Shin M., Won Y., Lee M., Kwak J.S., et al. Regulation of the catabolic cascade in osteoarthritis by the zinc-ZIP8-MTF1 axis. Cell 2014, 156(4):730-743.
8. Lees S., Golub S.B., Last K., Zeng W., Jackson D.C., Sutton P., et al. Bioactivity in an aggrecan 32-mer fragment is mediated via toll-like receptor 2. Arthritis Rheumatol 2015, 67(5):1240-1249.
9. Scanzello C.R., Goldring S.R. The role of synovitis in osteoarthritis pathogenesis. Bone 2012, 51(2):249-257.
10. van Lent P.L., Blom A.B., Schelbergen R.F., Sloetjes A., Lafeber F.P., Lems W.F., et al. Active involvement of alarmins S100A8 and S100A9 in the regulation of synovial activation and joint destruction during mouse and human osteoarthritis. Arthritis Rheum 2012, 64(5):1466-1476.
11. Schelbergen R.F., van Dalen S., ter Huurne M., Roth J., Vogl T., Noel D., et al. Treatment efficacy of adipose-derived stem cells in experimental osteoarthritis is driven by high synovial activation and reflected by S100A8/A9 serum levels. Osteoarthritis Cartilage 2014, 22(8):1158-1166.
12. Nasi S., Ea H.K., Chobaz V., van Lent P., Liote F., So A., et al. Dispensable role of myeloid differentiation primary response gene 88 (MyD88) and MyD88-dependent toll-like receptors (TLRs) in a murine model of osteoarthritis. Joint Bone Spine 2014, 81(4):320-324.
13. Jackson M.T., Moradi B., Zaki S., Smith M.M., McCracken S., Smith S.M., et al. Depletion of protease-activated receptor 2 but not protease-activated receptor 1 may confer protection against osteoarthritis in mice through extracartilaginous mechanisms. Arthritis Rheumatol 2014, 66(12):3337-3348.
14. Stoppiello L.A., Mapp P.I., Wilson D., Hill R., Scammell B.E., Walsh D.A. Structural associations of symptomatic knee osteoarthritis. Arthritis Rheumatol 2014, 66(11):3018-3027.
15. Lane N.E., Brandt K., Hawker G., Peeva E., Schreyer E., Tsuji W., et al. OARSI-FDA initiative: defining the disease state of osteoarthritis. Osteoarthritis Cartilage 2011, 19(5):478-482.
16. Johnson V.L., Hunter D.J. The epidemiology of osteoarthritis. Best Pract Res Clin Rheumatol 2014, 28(1):5-15.
17. Thijssen E., van Caam A., van der Kraan P.M. Obesity and osteoarthritis, more than just wear and tear: pivotal roles for inflamed adipose tissue and dyslipidaemia in obesity-induced osteoarthritis. Rheumatology (Oxford) 2015, 54(4):588-600.
18. McNeill J.N., Wu C.L., Rabey K.N., Schmitt D., Guilak F. Life-long caloric restriction does not alter the severity of age-related osteoarthritis. Age (Dordr) 2014, 36(4):9669.
19. Wu C.L., Jain D., McNeill J.N., Little D., Anderson J.A., Huebner J.L., et al. Dietary fatty acid content regulates wound repair and the pathogenesis of osteoarthritis following joint injury. Ann Rheum Dis 2014, [Epub ahead of print]. 10.1136/annrheumdis-2014-205601.
20. Cai A., Hutchison E., Hudson J., Kawashima Y., Komori N., Singh A., et al. Metabolic enrichment of omega-3 polyunsaturated fatty acids does not reduce the onset of idiopathic knee osteoarthritis in mice. Osteoarthritis Cartilage 2014, 22(9):1301-1309.
21. Malfait A.M., Little C.B. On the predictive utility of animal models of osteoarthritis. Arthritis Res Ther 2015, 17:225. 10.1186/s13075-015-0747-6.
22. Ratneswaran A., LeBlanc E.A., Walser E., Welch I., Mort J.S., Borradaile N., et al. Peroxisome proliferator-activated receptor delta promotes the progression of posttraumatic osteoarthritis in a mouse model. Arthritis Rheumatol 2015, 67(2):454-464.
23. Loeser R.F. Aging processes and the development of osteoarthritis. Curr Opin Rheumatol 2013, 25(1):108-113.
24. Mobasheri A., Matta C., Zakany R., Musumeci G. Chondrosenescence: definition, hallmarks and potential role in the pathogenesis of osteoarthritis. Maturitas 2015, 80(3):237-244.
25. Kroemer G. Autophagy: a druggable process that is deregulated in aging and human disease. J Clin Invest 2015, 125(1):1-4.
26. Lopez-Otin C., Blasco M.A., Partridge L., Serrano M., Kroemer G. The hallmarks of aging. Cell 2013, 153(6):1194-1217.
27. Carames B., Olmer M., Kiosses W.B., Lotz M.K. The relationship of autophagy defects to cartilage damage during joint aging in a mouse model. Arthritis Rheumatol 2015, 67(6):1568-1576.
28. Vasheghani F., Zhang Y., Li Y.H., Blati M., Fahmi H., Lussier B., et al. PPARgamma deficiency results in severe, accelerated osteoarthritis associated with aberrant mTOR signalling in the articular cartilage. Ann Rheum Dis 2015, 74(3):569-578.
29. Takayama K., Kawakami Y., Kobayashi M., Greco N., Cummins J.H., Matsushita T., et al. Local intra-articular injection of rapamycin delays articular cartilage degeneration in a murine model of osteoarthritis. Arthritis Res Ther 2014, 16(6):482.
30. Zhao X., Petursson F., Viollet B., Lotz M., Terkeltaub R., Liu-Bryan R. Peroxisome proliferator-activated receptor gamma coactivator 1alpha and FoxO3A mediate chondroprotection by AMP-activated protein kinase. Arthritis Rheumatol 2014, 66(11):3073-3082.
31. Akasaki Y., Alvarez-Garcia O., Saito M., Carames B., Iwamoto Y., Lotz M.K. FoxO transcription factors support oxidative stress resistance in human chondrocytes. Arthritis Rheumatol 2014, 66(12):3349-3358.
32. Akasaki Y., Hasegawa A., Saito M., Asahara H., Iwamoto Y., Lotz M.K. Dysregulated FOXO transcription factors in articular cartilage in aging and osteoarthritis. Osteoarthritis Cartilage 2014, 22(1):162-170.
33. Loeser R.F., Gandhi U., Long D.L., Yin W., Chubinskaya S. Aging and oxidative stress reduce the response of human articular chondrocytes to insulin-like growth factor 1 and osteogenic protein 1. Arthritis Rheumatol 2014, 66(8):2201-2209.
34. Furman B.D., Mangiapani D.S., Zeitler E., Bailey K.N., Horne P.H., Huebner J.L., et al. Targeting pro-inflammatory cytokines following joint injury: acute intra-articular inhibition of interleukin-1 following knee injury prevents post-traumatic arthritis. Arthritis Res Ther 2014, 16(3):R134.
35. Malfait A.M., Schnitzer T. Toward a mechanism-based approach of pain management in osteoarthritis. Nat Rev Rheumatol 2013, 9:654-664.
36. Schnitzer T.J., Marks J.A. A systematic review of the efficacy and general safety of antibodies to NGF in the treatment of OA of the hip or knee. Osteoarthritis Cartilage 2015, 23(Suppl 1):S8-S17.
37. Pecchi E., Priam S., Gosset M., Pigenet A., Sudre L., Laiguillon M.C., et al. Induction of nerve growth factor expression and release by mechanical and inflammatory stimuli in chondrocytes: possible involvement in osteoarthritis pain. Arthritis Res Ther 2014, 16(1):R16.
38. Blaney Davidson E.N., van Caam A.P., Vitters E.L., Bennink M.B., Thijssen E., van den Berg W.B., et al. TGF-beta is a potent inducer of nerve growth factor in articular cartilage via the ALK5-Smad2/3 pathway. Potential role in OA related pain?. Osteoarthritis Cartilage 2015, 23(3):478-486.
39. Ishikawa G., Koya Y., Tanaka H., Nagakura Y. Long-term analgesic effect of a single dose of anti-NGF antibody on pain during motion without notable suppression of joint edema and lesion in a rat model of osteoarthritis. Osteoarthritis Cartilage 2015, 23(6):925-932.
40. Bullock C.M., Wookey P., Bennett A., Mobasheri A., Dickerson I., Kelly S. Peripheral calcitonin gene-related peptide receptor activation and mechanical sensitization of the joint in rat models of osteoarthritis pain. Arthritis Rheumatol 2014, 66(8):2188-2200.
41. Benschop R.J., Collins E.C., Darling R.J., Allan B.W., Leung D., Conner E.M., et al. Development of a novel antibody to calcitonin gene-related peptide for the treatment of osteoarthritis-related pain. Osteoarthritis Cartilage 2014, 22(4):578-585.
42. Rahman W., Dickenson A.H. Osteoarthritis-dependent changes in antinociceptive action of Nav1.7 and Nav1.8 sodium channel blockers: an in vivo electrophysiological study in the rat. Neuroscience 2015, 295:103-116.
43. Rahman W., Dickenson A.H. Emerging targets and therapeutic approaches for the treatment of osteoarthritis pain. Curr Opin Support Palliat Care 2015, 9(2):124-130.